Director John Climax filed a Form 4 with the U.S. Securities and Exchange Commission on September 18, 2026, disclosing transactions in ICON PLC ordinary shares on September 16, 2026, traded on NASDAQ:ICLR.

Key Highlights

  • Option exercise: Dr. John Climax exercised 5,005 fully vested stock options at an exercise price of $125.74 per share on September 16, 2026.
  • Share sale: Following the exercise, 5,005 ordinary shares were sold at a price of $175 per share on the same date.
  • Resulting ownership: After the transactions, Dr. Climax directly beneficially owns 2,087 ordinary shares.
  • Option expiration: The exercised options were originally granted on May 18, 2018, and expire on the eighth anniversary of the grant date, subject to certain automatic extensions but no later than the tenth anniversary.
  • Foreign private issuer exemption: The filing notes that transactions are exempt from Sections 16(b) and 16(c) of the Securities Exchange Act of 1934 due to ICON PLC's status as a foreign private issuer.

ICON PLC Director Climax Reports Option Exercise and Share Disposal

According to the Form 4 filed on September 18, 2026, Dr. John Climax, a director of ICON PLC (NASDAQ:ICLR), reported two transactions in the company's ordinary shares dated September 16, 2026. First, Dr. Climax exercised 5,005 stock options at a conversion price of $125.74 per share, coded as an "M" transaction, which increased his directly held beneficial ownership to 7,092 ordinary shares following that acquisition.

Immediately after the exercise, the filing discloses that Dr. Climax sold all 5,005 of those acquired ordinary shares at a price of $175 per share, coded as an "S" transaction. Following this disposal, his direct beneficial ownership stood at 2,087 ordinary shares, according to the filing.

The filing states that the exercised stock options were fully vested and carried an exercise price of $125.74. The options are described as expiring on the eighth anniversary of the grant date, May 18, 2018, subject to automatic extension until the 30th trading day following any period during which exercise is prohibited under the issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date. The filing further notes, in a remarks section, that because ICON PLC is a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934, the reporting person's transactions in the issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act. The form was signed by Erina Joan Fox as Attorney-in-Fact on September 18, 2026.

What Was Disclosed

Dr. John Climax, a director of ICON PLC, disclosed the exercise of 5,005 fully vested stock options at $125.74 and the same-day sale of 5,005 ordinary shares at $175, leaving him with direct beneficial ownership of 2,087 ordinary shares.